SCHEMBL17304804

SCHEMBL17304804

CC(C)N1C[C@H](N)C[C@H](N)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17294904 1.00
SCHEMBL680704 0.88
Hydrochloric Acid SCHEMBL20241173 0.86
Hydrochloric Acid SCHEMBL2920993 0.86
SCHEMBL16379297 0.85
SCHEMBL16379295 0.85
SCHEMBL21343413 0.85
SCHEMBL19766606 0.85
SCHEMBL24789582 0.84 DPP4 (0.32)
SCHEMBL24857258 0.84 DPP4 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170183306-A1 CYCLIC COMPOUNDS HAVING A 1,3 DIAMINO-FUNCTIONALITY FOR USE IN THE TREATMENT OF HIV INFECTION UNIVERSITE PARIS DECARTES (FR) 2017-06-29 US disclosed
US-20170183306-A1 CYCLIC COMPOUNDS HAVING A 1,3 DIAMINO-FUNCTIONALITY FOR USE IN THE TREATMENT OF HIV INFECTION UNIVERSITE PARIS DECARTES (FR) 2017-06-29 US disclosed
WO-2015181387-A1 CYCLIC COMPOUNDS HAVING A 1,3 DIAMINO-FUNCTIONALITY FOR USE IN THE TREATMENT OF HIV INFECTION UNIVERSITE PARIS DESCARTES (FR) 2015-12-03 WO disclosed